Remedium Lifecare Share Price Target From 2024 to 2030: Remedium Lifecare is one of the new-age players in the health and pharmaceutical sector. It mainly focuses on manufacturing and distribution of pharmaceutical products for the diversified needs of healthcare from customers. Remedium Lifecare has gained growth with an assurance of innovation of healthcare solutions, which comes under the interest of people.
Although the company is quite small with a market capitalization of ₹210 Cr, the growth prospects have been very promising because of strategic initiatives and customer-centric healthcare solutions. Its efforts in improving product portfolios and operational efficiencies place it on the noted list in the health care industry.
Key Financial Highlights For Remedium Lifecare Share Price
- Low for the Day: ₹5.01
- High for the Day: ₹5.30
- 52-Week Low: ₹5.01
- 52-Week High: ₹38.25
- Open: ₹5.29
- Previous Close: ₹5.20
- Current Price: ₹5.21 (+0.19% over last 1 year)
- Number of Shares Traded: 4,98,492 shares
- Value Traded: ₹0.26 Cr
- Upper Circuit: ₹5.47
- Lower Circuit: ₹4.95
Fundamentals For Remedium Lifecare Share Price
- Market Capitalisation: ₹210 Cr
- P/E Ratio(TTM): 11.33
- P/B Ratio: 4.58
- Industry P/E: 61.90
- Debt to Equity: 3.95
- ROE: 40.24%
- EPS (TTM): ₹0.46
- Dividend Yield : 0.00
- Book Value: ₹1.14
- Face Value : ₹1
Share Holding Pattern For Remedium Lifecare Share Price
- Promoters: 1.11%
- Retail and Others: 98.89%
Promoter holding is at a low 1.11% and the high retail participation is 98.89%, making it reliant on public investors. During the September 2024 quarter, the promoter holding does not change and hence signifies stability in management.
Remedium Lifecare Share Price Target From 2024 to 2030
| Year | Share Price Target |
| 2024 | ₹40 |
| 2025 | ₹70 |
| 2026 | ₹100 |
| 2027 | ₹130 |
| 2028 | ₹160 |
| 2029 | ₹190 |
| 2030 | ₹220 |
2024: Remedium Lifecare Share Price Target ₹40
It will increase to ₹40 in the year 2024 due to aggressive growth strategies of the company and growing demand for pharmaceutical products. The company is going to increase its market share by improving access to its products.
2025: Remedium Lifecare Share Price Target ₹70
The share of the company’s share is going to hit ₹70 by the end of 2025. The ride is going to be easy as this target would see strategic collaborations, along with a long product list with continuous revenue increases coupled with surging requirements of low-priced health care treatments in the markets.
2026: Remedium Lifecare Share Price Target ₹100
Reach the mark of ₹100 in 2026 Remedium Lifecare should reach a mark of ₹100 in 2026. Improvement is seen in the trajectories for the company growth towards manufacturing base and in penetrating into new markets.
2027: Remedium Lifecare Share Price Target ₹130
Share price should see ₹ 130 by the end of the year 2027. The focus area of the company in relation to research and development or R&D and innovative areas in pharmaceuticals is of prime importance.
2028: Remedium Lifecare Share Price Target ₹160
The share price will be at ₹160 by 2028. With better operational efficiencies, the distribution of products throughout the wide product network will add a wider market presence to the company’s performance.
2029: Remedium Lifecare Share Price Target ₹190
Share price of the company will touch ₹190 by 2029. Proper investment in infrastructures and technology, followed by attention to customer satisfaction, would help the organization grow steadily.
2030: Remedium Lifecare Share Price Target ₹220
By 2030, the company Remedium Lifecare is to reach ₹220. In case the company sustains growth as well as adapts to dynamic changes in the market, then the company will exist in the healthcare industry.
Growth Drivers for Remedium Lifecare Share Price
- Healthcare Industry Expansion: The demand for available as well as affordable healthcare products increases the growth of the company Remedium Lifecare in the world arena.
- Innovations in Pharmaceuticals: Through Research and Development, products change and cater to the requirement emerging in the market
- Operating Efficiency: Cost cuts translating into improved margins through better optimization and manufacturing capacity would be achieved
- Market Expansion: More revenues would be drawn upon entry into new national or international markets
- Government Measures: The company would eventually benefit from the fact that the government is initiating healthier policies to make accessibility wider
Risks and Issues For Remedium Lifecare Share Price
Remedium Lifecare has immense growth potential, but there are some challenges and risks that need to be considered-
- High Debt-to-Equity Ratio: With a debt-to-equity ratio of 3.95, the company’s high debt levels may pose a risk to the stability of the financials.
- Low Promoter Holding: With only 1.11% promoter holding, there is less skin in the game for the management.
- Market Competition: The pharmaceutical industry is extremely competitive with a continuous process of innovation and efficiency required.
- Global or Domestic Economic Slowdowns: Growth of the company will be hampered due to an economic slowdown.
- Healthcare Regulation Change: Change in healthcare regulation may become detrimental to business performance and profitability.
Most Asked Questions About Remedium Lifecare Share Price
Q1. Remedium Lifecare Is it a good long-term investment?
A1. Of course, Remedium Lifecare has the promise to invest for the long haul due to its orientation of innovation, operational efficiency and expansion of market share, although investors have to bear risks in the form of a large debt-to-equity ratio.
Q2. Promoter holding is too low. Why?
A2. Very low holding in promoters at 1.11%, which tells that the management holding is very low too. It is quite natural, again, this is not something to really worry about it because both these companies are in stage of growth cycle and expand on public money
Q3. What can really push share price?
A3. Its increasing market footprint and R&D, the company’s focus; growing need for healthcare; operational efficiency would.
Q4. What are the risks of investing in Remedium Lifecare?
A4. Risks include a high level of debt, regulatory issues and stiff competition in the pharmaceutical industry.
Q5. Does the company pay dividend?
A5. Remedium Lifecare has not paid any dividends so far as it is still investing its earnings into further growth and expansion.
Q6. How does the company compare to its competitors?
A6. Despite being smaller than other major players, the company has a high ROE of 40.24% and is focused on innovation, thus one of the bright future healthcare sector companies.
Q7. What is the long-term prospect for the company Remedium Lifecare?
A7. Long-term positive prospect for the company, since it continues to focus on innovation, increases in market, and operational efficiency.
Remedium Lifecare is a very growth-oriented company, which is evidenced through the projected share price expectations that are indicative of sustained growth from 2024 through 2030. And then, innovation, customers’ satisfaction, and an increased market presence are some points that draw investors to this company.
This entails some risks such as high level of debt and very low promoter holding. Thus, in advance, the investor is to carry out a proper study, and then the investor should keep himself updated regarding the current market trend before he invests.
